Forus raised $150 million in a Series C follow-on round announced Sept. 8 that values the company at $3 billion, with funds earmarked to bring its product to new medical offices nationwide. The company said its AI platform, which assigns an AI agent to each prescription across every drug, payer and pharmacy, now supports patients in all 50 states and 85% of U.S. ZIP codes and aims to address administrative friction that prevents more than a third of patients prescribed complex or high-cost medications from receiving their first dose. Participating investors were not disclosed in the release.